|
SE9501384D0
(sv)
|
1995-04-13 |
1995-04-13 |
Astra Ab |
Process for the preparation of respirable particles
|
|
SE9701956D0
(sv)
|
1997-05-23 |
1997-05-23 |
Astra Ab |
New composition of matter
|
|
SK184799A3
(en)
*
|
1997-06-27 |
2000-06-12 |
Astra Ab |
New combination of antiasthma medicaments
|
|
SE9704186D0
(sv)
*
|
1997-11-14 |
1997-11-14 |
Astra Ab |
New composition of matter
|
|
GB9806477D0
(en)
*
|
1998-03-26 |
1998-05-27 |
Glaxo Group Ltd |
Improved crystals
|
|
GB2341120B
(en)
|
1998-09-04 |
2002-04-17 |
Aea Technology Plc |
Controlling uniformity of crystalline precipitates
|
|
SE9803770D0
(sv)
*
|
1998-11-05 |
1998-11-05 |
Astra Ab |
Dry powder pharmaceutical formulation
|
|
SE9804001D0
(sv)
*
|
1998-11-23 |
1998-11-23 |
Astra Ab |
New process
|
|
GB9826284D0
(en)
*
|
1998-12-01 |
1999-01-20 |
Rhone Poulence Rorer Limited |
Process
|
|
GB9826286D0
(en)
*
|
1998-12-01 |
1999-01-20 |
Rhone Poulence Rorer Limited |
Process
|
|
GB9828721D0
(en)
*
|
1998-12-24 |
1999-02-17 |
Glaxo Group Ltd |
Novel apparatus and process
|
|
GB9905512D0
(en)
*
|
1999-03-10 |
1999-05-05 |
Smithkline Beecham Plc |
Process
|
|
GB9919693D0
(en)
*
|
1999-08-19 |
1999-10-20 |
Rhone Poulenc Rorer Ltd |
Process
|
|
YU34501A
(sh)
|
2000-05-26 |
2003-10-31 |
Pfizer Products Inc. |
Postupak reaktivne kristalizacije radi povećanja veličine čestica
|
|
GB0016040D0
(en)
*
|
2000-06-29 |
2000-08-23 |
Glaxo Group Ltd |
Novel process for preparing crystalline particles
|
|
GB0015981D0
(en)
*
|
2000-06-29 |
2000-08-23 |
Glaxo Group Ltd |
Novel process for preparing crystalline particles
|
|
GB0016002D0
(en)
*
|
2000-06-29 |
2000-08-23 |
Glaxo Group Ltd |
Novel process for preparing crystalline particles
|
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
|
US7037528B2
(en)
|
2000-12-22 |
2006-05-02 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
|
US9700866B2
(en)
*
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
|
US20050048126A1
(en)
*
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
|
US6977085B2
(en)
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
|
US7193084B2
(en)
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
|
US6951656B2
(en)
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US6667344B2
(en)
|
2001-04-17 |
2003-12-23 |
Dey, L.P. |
Bronchodilating compositions and methods
|
|
US20030055026A1
(en)
|
2001-04-17 |
2003-03-20 |
Dey L.P. |
Formoterol/steroid bronchodilating compositions and methods of use thereof
|
|
JP2004530545A
(ja)
|
2001-05-05 |
2004-10-07 |
アクセンタス パブリック リミテッド カンパニー |
微小結晶の形成方法および装置
|
|
DE10137017A1
(de)
*
|
2001-07-30 |
2003-02-20 |
Basf Ag |
Kristallisationsverfahren zur Einstellung kleiner Partikel
|
|
EP1423096B1
(en)
*
|
2001-08-29 |
2006-08-16 |
Dow Global Technologies Inc. |
A process for preparing crystalline drug particles by means of precipitation
|
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
|
IL160570A0
(en)
*
|
2001-09-26 |
2004-07-25 |
Baxter Int |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
|
US7931022B2
(en)
*
|
2001-10-19 |
2011-04-26 |
Respirks, Inc. |
Method and apparatus for dispensing inhalator medicament
|
|
US20030203930A1
(en)
*
|
2001-10-26 |
2003-10-30 |
Imtiaz Chaudry |
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
|
|
US20030140920A1
(en)
*
|
2001-10-26 |
2003-07-31 |
Dey L.P. |
Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
|
|
US6702997B2
(en)
|
2001-10-26 |
2004-03-09 |
Dey, L.P. |
Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
|
|
US20030191151A1
(en)
*
|
2001-10-26 |
2003-10-09 |
Imtiaz Chaudry |
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
|
|
JP2003221335A
(ja)
|
2001-10-26 |
2003-08-05 |
Dey Lp |
慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
|
|
DK1476201T3
(da)
|
2002-02-19 |
2009-03-30 |
Resolution Chemicals Ltd |
Solvent-baseret sterilisering af steroider
|
|
DE10214031A1
(de)
*
|
2002-03-27 |
2004-02-19 |
Pharmatech Gmbh |
Verfahren zur Herstellung und Anwendung von Mikro- und Nanoteilchen durch aufbauende Mikronisation
|
|
FI20020857A7
(fi)
*
|
2002-05-07 |
2003-11-08 |
Focus Inhalation Oy |
Amorfisen aineen muuntaminen vastaavaksi kiteiseksi aineeksi spraykuivaamalla ja käyttämällä kiteistä spraykuivattua ainetta lääkevalmisteissa
|
|
EP3308772B8
(en)
*
|
2002-06-28 |
2021-03-17 |
Civitas Therapeutics, Inc. |
Inhalable epinephrine
|
|
GB0216700D0
(en)
|
2002-07-18 |
2002-08-28 |
Astrazeneca Ab |
Process
|
|
US20040023935A1
(en)
*
|
2002-08-02 |
2004-02-05 |
Dey, L.P. |
Inhalation compositions, methods of use thereof, and process for preparation of same
|
|
US20040028747A1
(en)
*
|
2002-08-06 |
2004-02-12 |
Tucker Christopher J. |
Crystalline drug particles prepared using a controlled precipitation process
|
|
US20040028746A1
(en)
*
|
2002-08-06 |
2004-02-12 |
Sonke Svenson |
Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
|
|
WO2004030659A1
(en)
*
|
2002-09-30 |
2004-04-15 |
Acusphere, Inc. |
Sustained release porous microparticles for inhalation
|
|
US20040109826A1
(en)
*
|
2002-12-06 |
2004-06-10 |
Dey, L.P. |
Stabilized albuterol compositions and method of preparation thereof
|
|
US6962006B2
(en)
*
|
2002-12-19 |
2005-11-08 |
Acusphere, Inc. |
Methods and apparatus for making particles using spray dryer and in-line jet mill
|
|
US20040121003A1
(en)
*
|
2002-12-19 |
2004-06-24 |
Acusphere, Inc. |
Methods for making pharmaceutical formulations comprising deagglomerated microparticles
|
|
US20060241130A1
(en)
*
|
2003-01-31 |
2006-10-26 |
Ehud Keinan |
Anti-inflammatory compositions and uses thereof
|
|
GB0302673D0
(en)
|
2003-02-06 |
2003-03-12 |
Astrazeneca Ab |
Pharmaceutical formulations
|
|
PE20040950A1
(es)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
|
DK1610878T3
(da)
*
|
2003-02-21 |
2014-12-01 |
Univ Bath |
Fremgangsmåde til fremstilling af partikler
|
|
US7041144B2
(en)
*
|
2003-03-04 |
2006-05-09 |
Five Star Technologies, Inc. |
Hydrodynamic cavitation crystallization process
|
|
US7511079B2
(en)
*
|
2003-03-24 |
2009-03-31 |
Baxter International Inc. |
Methods and apparatuses for the comminution and stabilization of small particles
|
|
JP5207432B2
(ja)
*
|
2003-04-29 |
2013-06-12 |
エム・エス・ディー・オス・ベー・フェー |
アンチ溶媒凝固プロセス
|
|
CN1819863A
(zh)
*
|
2003-06-10 |
2006-08-16 |
大正制药株式会社 |
放射形球状晶析物及其制造方法以及使用它的干粉制剂
|
|
SE0302029D0
(sv)
*
|
2003-07-07 |
2003-07-07 |
Astrazeneca Ab |
Novel process
|
|
TWI359675B
(en)
|
2003-07-10 |
2012-03-11 |
Dey L P |
Bronchodilating β-agonist compositions
|
|
JP2007520555A
(ja)
*
|
2004-02-05 |
2007-07-26 |
バクスター・インターナショナル・インコーポレイテッド |
自己安定化剤の使用により調製された分散剤
|
|
TWI341836B
(en)
|
2004-03-11 |
2011-05-11 |
Theravance Inc |
Biphenyl compounds useful as muscarinic receptor antagonists
|
|
US7498445B2
(en)
*
|
2004-05-05 |
2009-03-03 |
Renopharm Ltd. |
Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof
|
|
WO2005105765A1
(en)
*
|
2004-05-05 |
2005-11-10 |
Renopharm Ltd. |
Nitric oxide donors and uses thereof
|
|
US8134010B2
(en)
*
|
2004-05-05 |
2012-03-13 |
Renopharm Ltd. |
Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof
|
|
US7968575B2
(en)
*
|
2004-05-05 |
2011-06-28 |
Renopharm Ltd. |
Nitric oxide donors and uses thereof
|
|
EP1742615A2
(en)
*
|
2004-05-05 |
2007-01-17 |
Akzo Nobel N.V. |
Antisolvent emulsion solidification process
|
|
US20060009435A1
(en)
*
|
2004-06-23 |
2006-01-12 |
Joseph Kaspi |
Synthesis and powder preparation of fluticasone propionate
|
|
EP1833822A2
(en)
|
2004-08-16 |
2007-09-19 |
Theravance, Inc. |
Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
|
|
WO2006045795A2
(en)
*
|
2004-10-29 |
2006-05-04 |
Akzo Nobel N.V. |
Processes involving the use of antisolvent crystallization
|
|
US20060120972A1
(en)
*
|
2004-11-09 |
2006-06-08 |
Peter Engels |
9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension
|
|
DE102005011786A1
(de)
*
|
2005-03-11 |
2006-09-14 |
Pharmasol Gmbh |
Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen
|
|
EP1871344A4
(en)
*
|
2005-03-18 |
2012-05-02 |
Nanomaterials Tech Pte Ltd |
INHIBITABLE MEDICINAL PRODUCT
|
|
WO2006113309A1
(en)
|
2005-04-15 |
2006-10-26 |
Dr. Reddy's Laboratories Ltd. |
Lacidipine particles
|
|
US20060280787A1
(en)
*
|
2005-06-14 |
2006-12-14 |
Baxter International Inc. |
Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
|
|
WO2007011989A2
(en)
*
|
2005-07-15 |
2007-01-25 |
Map Pharmaceuticals, Inc. |
Multiple active pharmaceutical ingredients combined in discrete inhalation particles and formulations thereof
|
|
WO2007009164A1
(en)
*
|
2005-07-15 |
2007-01-25 |
Eiffel Technologies Limited |
Method of particle formation
|
|
US10532028B2
(en)
*
|
2005-07-28 |
2020-01-14 |
Isp Investments Llc |
Method to improve characteristics of spray dried powders and granulated materials, and the products thereby produced
|
|
US20070099883A1
(en)
*
|
2005-10-07 |
2007-05-03 |
Cheryl Lynn Calis |
Anhydrous mometasone furoate formulation
|
|
JP2009516003A
(ja)
*
|
2005-11-15 |
2009-04-16 |
バクスター・インターナショナル・インコーポレイテッド |
リポキシゲナーゼ阻害剤の組成物
|
|
US20070178166A1
(en)
*
|
2005-12-15 |
2007-08-02 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
WO2007070843A2
(en)
*
|
2005-12-15 |
2007-06-21 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for oral administration
|
|
US7913223B2
(en)
*
|
2005-12-16 |
2011-03-22 |
Dialogic Corporation |
Method and system for development and use of a user-interface for operations, administration, maintenance and provisioning of a telecommunications system
|
|
US20080085315A1
(en)
*
|
2006-10-10 |
2008-04-10 |
John Alfred Doney |
Amorphous ezetimibe and the production thereof
|
|
WO2008057048A1
(en)
*
|
2006-11-09 |
2008-05-15 |
Nanomaterials Technology Pte Ltd |
Nano & micro-sized particles of statin compounds and process for forming same
|
|
WO2008076780A2
(en)
*
|
2006-12-14 |
2008-06-26 |
Isp Investments Inc. |
Amorphous valsartan and the production thereof
|
|
US8613946B2
(en)
*
|
2006-12-21 |
2013-12-24 |
Isp Investment Inc. |
Carotenoids of enhanced bioavailability
|
|
WO2008080047A2
(en)
*
|
2006-12-23 |
2008-07-03 |
Baxter International Inc. |
Magnetic separation of fine particles from compositions
|
|
WO2008092046A2
(en)
*
|
2007-01-26 |
2008-07-31 |
Isp Investments Inc. |
Amorphous oxcarbazepine and the production thereof
|
|
CN101622302B
(zh)
*
|
2007-01-26 |
2013-01-23 |
Isp投资公司 |
生产喷雾干燥产品的制剂工艺方法
|
|
US20080293814A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Deepak Tiwari |
Concentrate esmolol
|
|
US8722736B2
(en)
*
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
|
US8426467B2
(en)
*
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
|
EP2191821A1
(en)
*
|
2008-11-26 |
2010-06-02 |
CHIESI FARMACEUTICI S.p.A. |
Microparticles comprising a salt of 8-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone having improved adhesion properties for dry powder inhalation
|
|
EP2393488B1
(en)
|
2009-02-06 |
2019-06-19 |
University Of Southern California |
Therapeutic compositions comprising monoterpenes
|
|
US20100291221A1
(en)
*
|
2009-05-15 |
2010-11-18 |
Robert Owen Cook |
Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation
|
|
US20100298602A1
(en)
*
|
2009-05-19 |
2010-11-25 |
Massachusetts Institute Of Technology |
Systems and methods for microfluidic crystallization
|
|
US20100294986A1
(en)
*
|
2009-05-19 |
2010-11-25 |
Massachusetts Institute Of Technology |
Supercritical fluid facilitated particle formation in microfluidic systems
|
|
PL2987490T3
(pl)
|
2009-07-15 |
2017-12-29 |
Theravance Biopharma R&D Ip, Llc |
Postacie krystaliczne wolnej zasady związku bifenylowego
|
|
US20110229437A1
(en)
*
|
2009-09-17 |
2011-09-22 |
Mutual Pharmaceutical Company, Inc. |
Method of Treating Asthma with Antiviral Agents
|
|
ES2683864T3
(es)
*
|
2009-10-01 |
2018-09-28 |
Adare Pharmaceuticals, Inc. |
Composiciones de corticosteroides administradas oralmente
|
|
MX338211B
(es)
|
2009-10-22 |
2016-03-30 |
Api Genesis Llc |
Metodos para hacer y utilizar composiciones que comprenden flavonoides.
|
|
EP3769754A1
(en)
|
2010-03-03 |
2021-01-27 |
Neonc Technologies, Inc. |
Pharmaceutical compositions comprising monoterpenes
|
|
CN101849910B
(zh)
*
|
2010-05-18 |
2012-02-22 |
重庆华邦制药股份有限公司 |
一种二丙酸倍他米松微粒的制备方法
|
|
ES2610810T3
(es)
|
2010-08-27 |
2017-05-03 |
Neonc Technologies Inc. |
Composiciones farmacéuticas que comprenden carbamatos de alcohol perilílico
|
|
US20160038600A1
(en)
|
2012-08-03 |
2016-02-11 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising poh derivatives
|
|
WO2012040228A2
(en)
|
2010-09-22 |
2012-03-29 |
Map Pharmaceuticals, Inc. |
Aerosol composition for administering drugs
|
|
CN105616391B
(zh)
|
2010-12-17 |
2021-03-19 |
尼昂克技术公司 |
使用异紫苏醇的方法和装置
|
|
CN102134236B
(zh)
*
|
2011-04-15 |
2013-07-24 |
北方民族大学 |
微细克拉霉素粉体的制备方法
|
|
KR20200117056A
(ko)
*
|
2011-07-08 |
2020-10-13 |
화이자 리미티드 |
플루티카손 프로피오네이트 형태 1의 제조 방법
|
|
RU2629085C2
(ru)
|
2011-10-11 |
2017-08-24 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
Кристаллические микрочастицы бета-агониста, покрытые жирной кислотой
|
|
DE102012221219B4
(de)
*
|
2012-11-20 |
2014-05-28 |
Jesalis Pharma Gmbh |
Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel
|
|
CN105142638B
(zh)
|
2013-03-15 |
2020-08-28 |
维罗纳制药公司 |
药物组合
|
|
WO2015034678A2
(en)
|
2013-09-06 |
2015-03-12 |
Aptalis Pharmatech, Inc. |
Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
|
|
HUE048020T2
(hu)
|
2014-05-12 |
2020-05-28 |
Verona Pharma Plc |
Új kezelés
|
|
WO2016007682A1
(en)
*
|
2014-07-08 |
2016-01-14 |
Amphastar Pharmaceuticals Inc. |
Micronized insulin, micronized insulin analogues, and methods of manufacturing the same
|
|
JP6674957B2
(ja)
|
2015-02-12 |
2020-04-01 |
ネオンク テクノロジーズ インク． |
ペリリルアルコール誘導体を含む医薬組成物
|
|
US10322168B2
(en)
|
2016-01-07 |
2019-06-18 |
Amphastar Pharmaceuticals, Inc. |
High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
|
|
TWI728172B
(zh)
|
2016-08-18 |
2021-05-21 |
美商愛戴爾製藥股份有限公司 |
治療嗜伊紅性食道炎之方法
|
|
DK3547836T3
(da)
|
2016-11-30 |
2024-11-18 |
Univ Southern California |
Perillylalkohol-3 brompyruvat-konjugat og fremgangsmåder til behandling af cancer
|
|
EP4389765A3
(en)
|
2018-02-08 |
2024-08-21 |
University of Southern California |
Methods of permeabilizing the blood brain barrier
|
|
US20210369667A1
(en)
|
2019-03-29 |
2021-12-02 |
Vizuri Health Sciences Consumer Healthcare, Inc. |
Compositions and methods for the prevention and treatment of radiation dermatitis, eczema, burns, wounds and certain cancers
|
|
CN114262316A
(zh)
*
|
2021-12-24 |
2022-04-01 |
嘉应学院 |
纳米橙皮素、其制备方法及所用双匀浆空化射流系统
|